Estrogen replacement therapy after treatment for localized breast carcinoma: Patient responses and opinions

Cancer

Volumn 78, Issue 5, 1996, Pages 1043-1048

  Vassilopoulou Sellin, Rena ^a   Klein, Mary Jean ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

breast carcinoma; estrogen replacement; menopause; patient attitudes

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POSTMENOPAUSE; PROSPECTIVE STUDIES;

EID: 0029817947     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960901)78:5<1043::AID-CNCR14>3.0.CO;2-2     Document Type: Article

References (38)

1. Hargrove JT, Eisenberg E. Menopause. Med Clin North Am 1995;79:1337-56.
2. Samsioe G. The menopause revisited. Int J Gynaecol Obstet 1995;51:1-13.
3. Greendale GA, Judd HL. The menopause: health implications and clinical management. J Am Geriatr Soc 1993; 41:426-36.
4. te Velde ER, van Leusden HAIM. Hormonal treatment for the climacteric: alleviation of symptoms and prevention of postmenopausal disease. Lancet 1994;343:654-8.
5. Wenger NK, Speroff L, Packard B. Cardiovascular health in women. N Engl J Med 1993;329:247-56.
6. Henderson BE, Paganini-Hill A, Ross RK. Estrogen replacement therapy and protection from acute myocardial infarction. Am J Obstet Gynecol 1988;159:312-7.
7. Riggs BL, Melton LJ III. Osteoporosis, the state-of-art. Semin Nucl Med 1987;17:283-92.
8. A special conference. Osteoporosis. National Conference on Women's Health Series, Bethesda, Maryland, October 30, 1987.
9. Utian WH, Schiff I. NAMS-Gallup survery on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapy. Menopause 1994;1:39-48.
10. Leather AT, Holland EFN, Studd JWW. The clinical problems of women referred to a specialist menopause clinic. J R Soc Med 1993;86:385-7.
11. Stenberg A, Heimer G, Ulmsten U. The prevalence of urogenital symptoms in postmenopausal women. Maturitas 1995;22:17-20.
12. Versi E, Cardozo L, Studd J, Brincat M, Cooper D. Urinary disorders and the menopause. Menopause 1995;2:89-95.
13. Lobo RA. Hormone replacement therapy. Oestrogen replacement after treatment for breast cancer? Lancet 1993;341:1313-4.
14. Marchant DJ. Estrogen-replacement therapy after breast cancer: risk versus benefits. Cancer 1993;71:2169-76.
15. Spicer DV, Pike MC. Hormone replacement after breast cancer. Lancet 1993;342:183-4.
16. Theriault RL, Vassilopoulou-Sellin R. A clinical dilemma: estrogen replacement therapy in postmenopausal women with a background of primary breast cancer. Ann Oncol 1991;2:709-7.
17. Powles TJ, Hickish T, Casey S, O'Brien M. Hormone replacement after breast cancer. Lancet 1993;243:60-1.
18. Creasman WT. Estrogen replacement therapy: is previously treated cancer a contraindication? Obstet Gynecol 1991; 77:309-12.
19. Stoll BA, Prbhoo S. Treatment of menopausal symptoms in breast cancer patients. Lancet 1988;1:1278-9.
20. Cobleigh MA, Berris RF, Bush T, Davidson NE, Robert NJ, Sparano JA, et al. Estrogen replacement therapy in breast cancer survivors, a time for change. JAAM 1994;272:540-5.
21. Vassilopoulou-Sellin R. Estrogen replacement therapy in women at increased risk for breast cancer. Breast Cancer Res Treat 1993;28:167-77.
22. Vassilopoulou-Sellin R, Zolinski C. Estrogen replacement therapy in women with breast cancer: a survey of patient attitudes. Am J Med Sci 1992;304:145-9.
23. Couzi RJ, Helzlsouer KJ, Petting JH. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 1995;13:2737-44.
24. Vassilopoulou-Sellin R, Theriault RL. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer. Monogr Natl Cancer Inst 1994; 16:153-9.
25. Manual for staging of cancer/American Joint Committee on Cancer. Beahrs O, Henson DE, Hutter RVP, Kennedy BGJ, editors. Staging of cancer. 4th edition. Philadelphia: JB Lippincott Co., Section: 25 Breast 1992:149-152.
26. Stamper MJ, Colditz GA, Willett WC, Manson JE, Posner B, Speized FE, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurse's Health Study. N Engl J Med 1991;325:745-62.
27. Pines A, Fishman EZ, Levo Y, Drory Y, Ben-ari E, et al. Menopause-induced changes in left ventricular wall thickness. Am J Cardiol 1993;72:240-1.
28. Ettinger B, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low dosage estrogen with calcium. Ann Intern Med 1987;106:40-5.
29. Naessen T, Perssson I, Adami HO, Bergstrom R, Bergkvist L. Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study. Ann Intern Med 1990;113:95-103.
30. Recker RR. Clinical review 41: current therapy for osteoporosis. J Clin Endocrinol Metab 1993;59:707-25.
31. Belchetz PE. Hormonal treatment of postmenopausal women. N Engl J Med 1994;330:1062-72.
32. Ravn SH, Rosenberg J, Bostofte E. Postmenopausal hormone replacement therapy - clinical implications. Eur J Obstet Gynecol Reprod Biol 1994;53:8193.
33. DiSaia PH, Grosen EA, Odicino F, Cowan B, Pecorelli S, Wile AG, et al. Replacement therapy for breast cancer survivors. Cancer 1995;76:2075-8.
34. Eden JA, Bush T, Nand S, Wren BG. A case-control study of combined continuous estrogen-progestin replacement therapy among women with personal history of breast cancer. Menopause 1995;2:67-72.
35. Wile AG, Opfell RW, Margileth DA. Horome replacement therapy in previously treated breast cancer patients. Am J Surg 1993;165:372-5.
36. Vassilopoulou-Sellin R, Theriault RL, Klein MJ. Estrogen replacement therapy in women with prior diagnosis and treatment of breast cancer. In: American Society of Clinical Oncology 32nd Annual Meeting, Philadelphia, May 18, 1996.
37. Cotton P. Environmental estrogenic agents area for concern: medical news and perspectives. JAMA 1994;271:414-5.
38. Knight DC, Eden JA. Phytoestrogens - a short review. Maturitas 1995;22:167-75.